🇺🇸 FDA
Pipeline program

OPDIVO 10 mg/mL concentrate for solution for infusion., OPDIVO 10 mg/mL concentrate for solution for infusion., US Opdivo

MB11-C-01-25

Phase 3 small_molecule active

Quick answer

OPDIVO 10 mg/mL concentrate for solution for infusion., OPDIVO 10 mg/mL concentrate for solution for infusion., US Opdivo for Previously Untreated Advanced (Unresectable or Metastatic) Melanoma is a Phase 3 program (small_molecule) at Mabxience Research SL with 1 ClinicalTrials.gov record(s).

Program details

Company
Mabxience Research SL
Indication
Previously Untreated Advanced (Unresectable or Metastatic) Melanoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials